Spectral-domain versus time domain optical coherence tomography before and after ranibizumab for age-related macular degeneration.
Ophthalmic Res 46(3):152-9 (2011) PMID 21389740
To study the ability to appreciate qualitative features that indicate disease activity in patients with neovascular age-related macular degeneration (AMD) and to analyze the differences in automated retinal thickness measurement, using 1 time domain optical coherence tomography (TD-OCT) and 2 different spectral-domain OCT (SD-OCT) machines.
DOI: 10.1159/000325027
Version: za2963e q8za4 q8zba q8zc7 q8zd1 q8ze2 q8zfd q8zg8